Intracranial Subependymoma: A SEER Analysis 2004-2013. World Neurosurg 2017 May;101:599-605
Date
02/25/2017Pubmed ID
28232153DOI
10.1016/j.wneu.2017.02.019Scopus ID
2-s2.0-85016451526 (requires institutional sign-in at Scopus site) 29 CitationsAbstract
BACKGROUND: Subependymomas are rare, slow-growing, benign tumors. Because they are scarce, knowledge relating to survival remains lacking. Consequently, we explore the SEER database to evaluate prognostic and treatment factors associated with intracranial subependymoma.
METHODS: With the SEER-18 registry database, information from all patients with intracranial subependymoma diagnosed during 2004-2013 were extracted, including age, sex, race, occurrence of surgery, extent of primary surgery, receipt of radiation, tumor size, and follow-up data. Age-adjusted incidence rates, overall survival, and cause-specific survival were calculated. Cox proportional hazards model was used for both univariate and multivariate analyses.
RESULTS: Four hundred sixty-six cases were identified. The overall incidence of intracranial subependymoma is 0.055 per 100,000 person-years (95% confidence interval, 0.05-0.06). Through multivariate analysis, age <40 years (hazard ratio [HR], 0.21; P = 0.03), female sex (HR, 0.34; P = 0.03), location within ventricles or near brainstem (HR, 0.49; P = 0.04), and occurrence of surgery (HR, 0.50; P = 0.02) were significant independent positive prognostic factors. Receipt of radiation did not show a significant relationship.
CONCLUSION: Clinical factors such as younger age, female sex, and location within ventricles or near brain stem demonstrated positive relationship with overall survival. For treatment options, surgery remains a mainstay option. No support for radiation therapy was identified.
Author List
Nguyen HS, Doan N, Gelsomino M, Shabani SAuthor
Saman Shabani MD Assistant Professor in the Neurosurgery department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdolescentAdult
Age Factors
Aged
Aged, 80 and over
Brain Neoplasms
Child
Child, Preschool
Databases, Factual
Female
Follow-Up Studies
Glioma, Subependymal
Humans
Infant
Male
Middle Aged
Registries
SEER Program
Sex Factors
Young Adult